Quarry LP Arcturus Therapeutics Holdings Inc. Transaction History

Quarry LP

$470 Billion
Q2 2025

A detailed history of Quarry LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Quarry LP holds 1,500 shares of ARCT stock, worth $32,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,500

Holding current value

$32,820

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$8.91 - $14.41 $13,365 - $21,615	1,500 New	1,500 $19.5 Million
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $1,095 - $1,997	45 New	45 $1.1 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

Federated Hermes, Inc. Pittsburgh, PA

4.69M
Shares

$103 Million
0.12% of portfolio
Black Rock Inc. New York, NY

2.65M
Shares

$58 Million
0.0% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

1.83M
Shares

$40.1 Million
0.02% of portfolio
Nikko Asset Management Americas, Inc.

1.83M
Shares

$40 Million
0.25% of portfolio
Vanguard Group Inc Valley Forge, PA

1.81M
Shares

$39.6 Million
0.0% of portfolio

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.

Account